Paper Review Records
全部论文审稿周期
5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
177
天
DPP9 modulates RPA1 stability and temozolomide sensitivity through RFWD3 Nuclear localization in glioma
作者
Wei Wang; Chang Che; Feng Wang; Bing Lu; Jianfei Huang; Sujie Ni展开收起
作者单位
1. https://ror.org/001rahr89grid.440642.00000 0004 0644 5481Clinical and Translational Research Center, Affiliated Hospital of Nantong University & Medical School of Nantong University,Nantong, Jiangsu 226001 China; 2. https://ror.org/001rahr89grid.440642.00000 0004 0644 5481Department of Oncology, Affiliated Hospital of Nantong University,Nantong, Jiangsu 226001 China; 3. https://ror.org/02afcvw97grid.260483.b0000 0000 9530 8833Department of Clinical Medicine, Xinling College of Nantong University,Nantong, Jiangsu 226001 China展开收起
64
天
OTUD1-mediated deubiquitination stabilizes SLC7A11 to suppress ferroptosis in hepatocellular carcinoma
作者
Runtian Li; Huanye Mo; Lei Zhang; Qingguang Liu; Kangsheng Tu展开收起
作者单位
1. https://ror.org/02tbvhh96grid.452438.c0000 0004 1760 8119Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University,Xi’an, Shaanxi 710061 China; 2. https://ror.org/02tbvhh96grid.452438.c0000 0004 1760 8119Department of Abdominal Surgery, The First Affiliated Hospital of Xi’an Jiaotong University,Xi’an, Shaanxi 710061 China展开收起
101
天
Integrative machine learning reveals a TLS signature and CCL5-CCR1 axis-associated immune remodeling in breast cancer
作者
Chuyi Wang; Pengcheng Ding; Wei Ouyang; Yunhai Ding; Meilin Lu; Tianyi Li; Yunxing Xu; Liangfeng Zheng; Kai Chen; Feiyue Ji; Min Dai; Guiyuan Gu; Xiaomin Lu展开收起
作者单位
1. https://ror.org/02afcvw97grid.260483.b0000 0000 9530 8833Department of Pathology, Affiliated Haian Hospital of Nantong University,Nantong, China; 2. https://ror.org/02afcvw97grid.260483.b0000 0000 9530 8833Central Laboratory, Affiliated Haian Hospital of Nantong University,Nantong, China; 3. https://ror.org/02afcvw97grid.260483.b0000 0000 9530 8833Department of Breast Center, Affiliated Haian Hospital of Nantong University,Nantong, China; 4. https://ror.org/00p991c53grid.33199.310000 0004 0368 7223Department of Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan, Hubei China; 5. https://ror.org/02afcvw97grid.260483.b0000 0000 9530 8833Department of Informatics, Affiliated Haian Hospital of Nantong University,Nantong, China; 6. https://ror.org/02afcvw97grid.260483.b0000 0000 9530 8833Department of Oncology, Affiliated Haian Hospital of Nantong University,Nantong, China展开收起
138
天
RNA-binding protein RALYL-mediated BCL11B RNA stability promotes immune escape in small cell lung cancer through transcriptional activation of BUB3
作者
Jiayue Shao; Shuangqing Liu; Ling Qin; Ningning Fan; Qi Sun; Qingwei Meng展开收起
作者单位
1. https://ror.org/01f77gp95grid.412651.50000 0004 1808 3502Department of Medical Oncology, Harbin Medical University Cancer Hospital,No. 150, Haping Road, Harbin, Heilongjiang 150081 P.R. China; 2. https://ror.org/01f77gp95grid.412651.50000 0004 1808 3502Department of Pathology, Harbin Medical University Cancer Hospital,Harbin, Heilongjiang 150081 P.R. China; 3. https://ror.org/05vy2sc54grid.412596.d0000 0004 1797 9737Department of Clinical Laboratory, the First Affiliated Hospital of Harbin Medical University,Harbin, Heilongjiang 150001 P.R. China展开收起
385
天
Inhibition of DLX6 sensitizes lung adenocarcinoma to cisplatin via GPX4-dependent ferroptosis
作者
Zedong Sun; Minmin Zhou; Can Wang; Mingrui Liu; Ningdan Song; Simian He; Feifan Ji; Jiayu Chen; Lin Xu; Xiufen Zheng; Binhui Ren展开收起
作者单位
1. https://ror.org/03108sf43grid.452509.f0000 0004 1764 4566Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research,Nanjing, People’s Republic of China; 2. Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Cancer Institute of Jiangsu Province, Nanjing, People’s Republic of China; 3. https://ror.org/059gcgy73grid.89957.3a0000 0000 9255 8984The Fourth Clinical College of Nanjing Medical University,Nanjing, People’s Republic of China; 4. https://ror.org/01sfm2718grid.254147.10000 0000 9776 7793China Pharmaceutical University,Nanjing, People’s Republic of China; 5. https://ror.org/03108sf43grid.452509.f0000 0004 1764 4566Department of Thoracic Surgery, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research,Nanjing, People’s Republic of China; 6. https://ror.org/004eeze55grid.443397.e0000 0004 0368 7493Department of Pharmacy and Engineering Research Center of Tropical Medicine Innovation and Transformation, Key Laboratory of Emergency and Trauma of Ministry of Education, The First Affiliated Hospital, Hainan Medical University,31 Longhua Road, Haikou, People’s Republic of China; 7. https://ror.org/03108sf43grid.452509.f0000 0004 1764 4566Department of Thoracic Surgery, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Jiangsu Cancer Hospital and Nanjing Medical University Affiliated Cancer Hospital and Jiangsu Institute of Cancer Research,42 Baiziting Road, Nanjing, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天